Form 8-K - Current report:
SEC Accession No. 0001564590-20-049634
Filing Date
2020-11-02
Accepted
2020-11-02 16:06:00
Documents
3
Period of Report
2020-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20201102.htm 8-K 32205
2 EX-99.1 abio-ex991_6.htm EX-99.1 153619
3 GRAPHIC gn4cakdeb5jc000001.jpg GRAPHIC 20861
  Complete submission text file 0001564590-20-049634.txt   216039
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 201280492
SIC: 2835 In Vitro & In Vivo Diagnostic Substances